Evaluation of Headache Intensity and Treatment Associated With Subarachnoid Hemorrhage

Tamara Langley; Debra Hampton; Amanda Wiggins; Justin Fraser

doi:10.1016/j.nurpra.2021.05.006

Evaluation of Headache Intensity and Treatment Associated With Subarachnoid Hemorrhage

Tamara Langley, Debra Hampton, Amanda Wiggins, Justin Fraser

Research output: Contribution to journal › Article › peer-review

Abstract

The purpose of this study was to determine the maximum daily patient-reported pain scores for those patients who experienced subarachnoid hemorrhage (SAH) and to assess how medications were used. A retrospective review of the electronic records of patients who experienced SAH was performed to evaluate patient demographics and comorbidities. The daily pain scores were statistically significant on day 5. Morphine equivalent dosing for day 1 admissions was as follows: patients with a Hunt and Hess (HH) score of I = 2.69, II = 5.52, and III = 0.86 (P = .009). Patients with SAH with an HH score of I and II had similar headaches but received more acetaminophen than patients with an HH score of III.AU

Original language	English
Pages (from-to)	995-998
Number of pages	4
Journal	Journal for Nurse Practitioners
Volume	17
Issue number	8
DOIs	https://doi.org/10.1016/j.nurpra.2021.05.006
State	Published - Sep 2021

Bibliographical note

Publisher Copyright:
© 2021 Elsevier Inc.

Keywords

Hunt Hess scoring
headache
headache pain scores
medication administration
subarachnoid hemorrhage

ASJC Scopus subject areas

Advanced and Specialized Nursing

Access to Document

10.1016/j.nurpra.2021.05.006

Cite this

@article{3aa8f55b1d3b47b1aff06540727b5739,

title = "Evaluation of Headache Intensity and Treatment Associated With Subarachnoid Hemorrhage",

abstract = "The purpose of this study was to determine the maximum daily patient-reported pain scores for those patients who experienced subarachnoid hemorrhage (SAH) and to assess how medications were used. A retrospective review of the electronic records of patients who experienced SAH was performed to evaluate patient demographics and comorbidities. The daily pain scores were statistically significant on day 5. Morphine equivalent dosing for day 1 admissions was as follows: patients with a Hunt and Hess (HH) score of I = 2.69, II = 5.52, and III = 0.86 (P = .009). Patients with SAH with an HH score of I and II had similar headaches but received more acetaminophen than patients with an HH score of III.AU",

keywords = "Hunt Hess scoring, headache, headache pain scores, medication administration, subarachnoid hemorrhage",

author = "Tamara Langley and Debra Hampton and Amanda Wiggins and Justin Fraser",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = sep,

doi = "10.1016/j.nurpra.2021.05.006",

language = "English",

volume = "17",

pages = "995--998",

number = "8",

}

TY - JOUR

T1 - Evaluation of Headache Intensity and Treatment Associated With Subarachnoid Hemorrhage

AU - Langley, Tamara

AU - Hampton, Debra

AU - Wiggins, Amanda

AU - Fraser, Justin

PY - 2021/9

Y1 - 2021/9

N2 - The purpose of this study was to determine the maximum daily patient-reported pain scores for those patients who experienced subarachnoid hemorrhage (SAH) and to assess how medications were used. A retrospective review of the electronic records of patients who experienced SAH was performed to evaluate patient demographics and comorbidities. The daily pain scores were statistically significant on day 5. Morphine equivalent dosing for day 1 admissions was as follows: patients with a Hunt and Hess (HH) score of I = 2.69, II = 5.52, and III = 0.86 (P = .009). Patients with SAH with an HH score of I and II had similar headaches but received more acetaminophen than patients with an HH score of III.AU

AB - The purpose of this study was to determine the maximum daily patient-reported pain scores for those patients who experienced subarachnoid hemorrhage (SAH) and to assess how medications were used. A retrospective review of the electronic records of patients who experienced SAH was performed to evaluate patient demographics and comorbidities. The daily pain scores were statistically significant on day 5. Morphine equivalent dosing for day 1 admissions was as follows: patients with a Hunt and Hess (HH) score of I = 2.69, II = 5.52, and III = 0.86 (P = .009). Patients with SAH with an HH score of I and II had similar headaches but received more acetaminophen than patients with an HH score of III.AU

KW - Hunt Hess scoring

KW - headache

KW - headache pain scores

KW - medication administration

KW - subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=85107134570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107134570&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2021.05.006

DO - 10.1016/j.nurpra.2021.05.006

M3 - Article

AN - SCOPUS:85107134570

SN - 1555-4155

VL - 17

SP - 995

EP - 998

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

IS - 8

ER -

Evaluation of Headache Intensity and Treatment Associated With Subarachnoid Hemorrhage

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this